Large-scale testing (Phase 3)Enrolling By InvitationNCT06679881
What this trial is testing
Long-Term, Open-label Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE
Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 170